Lv5
1061 积分 2021-11-22 加入
[Chinese guideline for diagnosis and management of drug-induced liver injury (2023 version)]
20小时前
待确认
Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas
15天前
已完结
The Tumor Lysis Syndrome
15天前
已完结
Chimeric antigen receptor T-cell therapy — assessment and management of toxicities
15天前
已完结
LY007, a Novel Anti-CD20 CAR-T Cell Therapy for Relapsed or Refractory B Cell Non-Hodgkin Lymphoma (R/R B-NHL): Results from a Phase 1 Study
15天前
已关闭
CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results
15天前
已完结
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
15天前
已完结
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
15天前
已完结
Treatment of Primary Progressive Hodgkin’s and Aggressive Non-Hodgkin’s Lymphoma: Is There a Chance for Cure?
15天前
已关闭
Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma
15天前
已完结
皖公网安备34019202002308
